| Line 5: | Line 5: | ||
*This page is for referencing possible therapeutic (medicinal) '''benefits''' of nicotine. | *This page is for referencing possible therapeutic (medicinal) '''benefits''' of nicotine. | ||
==Addiction (Nicotine)== | ==Addiction / Abuse Liability (Nicotine)== | ||
===2013 [https://www.federalregister.gov/documents/2013/04/02/2013-07528/modifications-to-labeling-of-nicotine-replacement-therapy-products-for-over-the-counter-human-use Modifications To Labeling of Nicotine Replacement Therapy Products for Over-the-Counter Human Use]=== | ===2013 [https://www.federalregister.gov/documents/2013/04/02/2013-07528/modifications-to-labeling-of-nicotine-replacement-therapy-products-for-over-the-counter-human-use Modifications To Labeling of Nicotine Replacement Therapy Products for Over-the-Counter Human Use]=== | ||
| Line 11: | Line 12: | ||
*[https://www.govinfo.gov/content/pkg/FR-2013-04-02/pdf/2013-07528.pdf PDF Version] | *[https://www.govinfo.gov/content/pkg/FR-2013-04-02/pdf/2013-07528.pdf PDF Version] | ||
*Citation: Food and Drug Administration, 78 FR 19718 | *Citation: Food and Drug Administration, 78 FR 19718 | ||
===2012 [https://academic.oup.com/ntr/article-abstract/14/1/75/1047894?redirectedFrom=fulltext Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence]=== | ===2012 [https://academic.oup.com/ntr/article-abstract/14/1/75/1047894?redirectedFrom=fulltext Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence]=== | ||
| Line 17: | Line 19: | ||
*Citation: Karl Fagerström, Ph.D., Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence, Nicotine & Tobacco Research, Volume 14, Issue 1, January 2012, Pages 75–78, doi: 10.1093/ntr/ntr137 | *Citation: Karl Fagerström, Ph.D., Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence, Nicotine & Tobacco Research, Volume 14, Issue 1, January 2012, Pages 75–78, doi: 10.1093/ntr/ntr137 | ||
===2002 [https://pubmed.ncbi.nlm.nih.gov/12175452/ Flavor improvement does not increase abuse liability of nicotine chewing gum]=== | |||
*Mint-flavored nicotine gum was rated as more palatable than the original nicotine gum, but the improvement in flavor did not increase abuse liability in adults (22 – 50 years old) or young adults (18 –21 years old). | |||
*[https://sci-hub.se/10.1016/s0091-3057(02)00723-2 PDF Version] | |||
*Citation: Houtsmuller EJ, Fant RV, Eissenberg TE, Henningfield JE, Stitzer ML. Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav. 2002 Jun;72(3):559-68. doi: 10.1016/s0091-3057(02)00723-2. PMID: 12175452. | |||
*Acknowledgement: This study was supported by SmithKline Beecham Consumer Healthcare. | |||
<br> | |||
<br> | |||
==Addiction (Nicotine with the use or abuse of recreational substances)== | ==Addiction (Nicotine with the use or abuse of recreational substances)== | ||
edits